Advisors Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Sell |
|
|||||
|
2025
Q1 | $4.07M | Buy |
|
|||||
|
2024
Q4 | $4.97M | Sell |
|
|||||
|
2024
Q3 | $4.44M | Buy |
|
|||||
|
2024
Q2 | $4.68M | Buy |
|
|||||
|
2024
Q1 | $4.5M | Buy |
|
|||||
|
2023
Q4 | $3.02M | Buy |
|
|||||
|
2023
Q3 | $2.44M | Sell |
|
|||||
|
2023
Q2 | $2.63M | Sell |
|
|||||
|
2023
Q1 | $2.82M | Buy |
|
|||||
|
2022
Q4 | $3.27M | Buy |
|
|||||
|
2022
Q3 | $2.29M | Buy |
|
|||||
|
2022
Q2 | $1.97M | Buy |
|
|||||
|
2022
Q1 | $1.45M | Sell |
|
|||||
|
2021
Q4 | $1.6M | Sell |
|
|||||
|
2021
Q3 | $1.93M | Sell |
|
|||||
|
2021
Q2 | $2.16M | Buy |
|
|||||
|
2021
Q1 | $2.06M | Buy |
|
|||||
|
2020
Q4 | $1.97M | Buy |
|
|||||
|
2020
Q3 | $1.71M | Sell |
|
|||||
|
2020
Q2 | $2.24M | Buy |
|
|||||
|
2020
Q1 | $1.3M | Buy |
|
|||||
|
2019
Q4 | $1.36M | Buy |
|
|||||
|
2019
Q3 | $1.08M | Buy |
|
|||||
|
2019
Q2 | $619K | Sell |
|
|||||
|
2019
Q1 | $925K | Buy |
|
|||||
|
2018
Q4 | $726K | Buy |
|
|||||
|
2018
Q3 | $864K | Buy |
|
|||||
|
2018
Q2 | $334K | Buy |
|